白云山(00874)于白云山生物的持股比例维持不变 仍为50%

智通财经
30 Jun

智通财经APP讯,白云山(00874)公布,于2025年6月30日,公司与广药创投基金、广州老字号基金、广药产投基金、国资并购基金、拜迪生物白云山生物订立了增资协议,增资协议于同日正式生效。

本次增资完成后,公司于白云山生物的直接及间接持股比例维持不变,仍为50.00%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10